Prediction of breast cancer using volatile biomarkers in the breath
暂无分享,去创建一个
Olaf Tietje | M. Phillips | R. Cataneo | J. Greenberg | O. Tietje | R. Gunawardena | Michael Phillips | B. Ditkoff | Renee N. Cataneo | Joel Greenberg | Beth Ann Ditkoff | Peter E Fisher | Peter Fisher | Ratnasiri Gunawardena | Cynthia Wong | C. Stephan Kwon | C. S. Kwon | Cynthia Wong
[1] M. Phillips. Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.
[2] K. Paull,et al. Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin. , 1996, Biochemical pharmacology.
[3] S Ciatto,et al. Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review , 2003, British Journal of Cancer.
[4] M. Phillips,et al. Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.
[5] C. Olsen,et al. Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. , 2001, Bioorganic & medicinal chemistry.
[6] M. Phillips,et al. Prediction of heart transplant rejection with a breath test for markers of oxidative stress. , 2004, The American journal of cardiology.
[7] I. Modai,et al. Fuzzy Logic Detection of Medically Serious Suicide Attempt Records in Major Psychiatric Disorders , 2004, The Journal of nervous and mental disease.
[8] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[9] M. Phillips,et al. Increased breath biomarkers of oxidative stress in diabetes mellitus. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[10] Joachim Schneider,et al. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. , 2003, Anticancer research.
[11] M. Yazdanpanah,et al. Cytotoxic aldehydes as possible markers for childhood cancer. , 1997, Free radical biology & medicine.